Haemonetics HAE Hospital — Costs incurred, net of reversals
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCharges.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's hospital — costs incurred, net of reversals.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Haemonetics's hospital — costs incurred, net of reversals?
- Haemonetics (HAE) reported hospital — costs incurred, net of reversals of $95K in Q1 2026.
- How has Haemonetics's hospital — costs incurred, net of reversals changed year-over-year?
- Haemonetics's hospital — costs incurred, net of reversals decreased by 63.5% year-over-year, from $260K to $95K.
- What is the long-term trend for Haemonetics's hospital — costs incurred, net of reversals?
- Over 4 years (2022 to 2026), Haemonetics's hospital — costs incurred, net of reversals has grown at a 94.3% compound annual growth rate (CAGR), from -$93K to $1.33M.
- What does hospital — costs incurred, net of reversals mean?
- Captures the net expenses recognized by the hospital segment after accounting for any reversals of previously accrued costs. This metric reflects the operational burden of specific initiatives or non-recurring events within the hospital business unit.